microfluidics
Altratech Nabs €10.5M in Financing to Support POC Test Development, Commercialization
The Ireland-based firm said that the financing will support clinical trials of an HIV test and help the company to strengthen its product pipeline.
AMDI Developing 10-Minute Point-of-Care PCR System, Pursuing CLIA Waiver for Respiratory Panel
Premium
The Fast PCR System uses novel sample prep, ultra-fast PCR, and spinning disk-based microfluidics.
Roche to Acquire LumiraDx Point-of-Care Testing Tech for up to $350M
Roche expects to integrate the POC clinical chemistry and immunoassay tests into its Diagnostics business when the acquisition closes in mid-2024.
Sphere Fluidics is the sole commercial partner and has the right to commercialize any resulting technology.
The firm's platform combines single-cell microbiology and machine learning to deliver a result in four to six hours.
Dec 16, 2022
Nov 18, 2022
Jun 17, 2022
Jun 3, 2022
May 20, 2021
Mar 31, 2021